Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.PerkinElmer has expanded its fetal, maternal and neonatal health screening capability in India, with the inauguration of the PerkinElmer Health Sciences laboratory.
Subscribe to our email newsletter
The new laboratory, located in Chennai, will feature PerkinElmer’s advanced technologies for diagnosing common and serious health issues in expecting mothers and babies in India, including prenatal testing for down syndrome and other genetic disorders, maternal testing for pre-eclampsia, diabetes, thyroid disorders, and infectious disease, and newborn testing for potentially fatal inherited and metabolic disorders.
In addition, PerkinElmer collaborated with MediScan Systems, in support of the its fetal and maternal health program.
Ann-Christine Sundell, president of genetic screening at PerkinElmer, said: “PerkinElmer is delighted to announce the opening of our new laboratory in Chennai which brings greater availability of fetal, maternal and newborn screening to mothers and children in India. Of the more than 25 million babies born annually in India today, only a small percentage have access to medical screening to detect and treat health issues. In partnership with local leaders in fetal medicine, we look forward to improving family health outcomes.”
PerkinElmer India is a wholly-owned subsidiary of PerkinElmer, operates as a direct sales, service and marketing operation. PerkinElmer India serves approximately 1,500 customers across various industries, including pharmaceutical, government, environmental, petrochemical and chemical.
MediScan is the referral diagnostic ultrasound centre in South India and has grown into one of the tertiary referral centres for Fetal Medicine in the region. The centre performs about 25,000 scans and over 3,000 fetal diagnostic and therapeutic procedures per year.